Pyroptosis Modulators: New Insights of Gasdermins in Health and Disease

Imane Allali-Boumara1, Ana Dácil Marrero1,2,3, Ana R Quesada1,2,3

  • 1Andalucía Tech, Departamento de Biología Molecular y Bioquímica, Facultad de Ciencias, Universidad de Málaga, E-29071 Málaga, Spain.

PubMed

Insights

Pyroptosis, an inflammatory cell death, involves gasdermin proteins forming pores. Oxidation influences gasdermin activation, offering new therapeutic strategies for inflammation and cancer.

Area of Science:

  • Cellular Biology
  • Immunology
  • Biochemistry

Background:

  • Pyroptosis is a key inflammatory cell death pathway.
  • Gasdermin proteins are central effectors of pyroptosis, forming membrane pores.
  • Oxidation is a newly identified regulator of gasdermin activation.

Purpose of the Study:

  • To review current knowledge on pyroptosis and human gasdermins.
  • To focus on gasdermin structure, function, and roles in health and disease.
  • To highlight the role of gasdermins in cancer and potential therapeutic strategies.

Main Methods:

  • Literature review of pyroptosis and gasdermin research.
  • Analysis of molecular structures and functions of gasdermin family members.
  • Synthesis of findings on gasdermins in inflammatory diseases and cancer.

Main Results:

  • Gasdermins undergo structural changes to form pores, releasing inflammatory molecules.
  • Oxidative modifications are critical for the activation of specific gasdermins.
  • Gasdermin dysregulation is implicated in various inflammatory conditions and cancer progression.

Conclusions:

  • Modulating pyroptosis and gasdermin activity, including via redox state, shows therapeutic promise.
  • Targeting gasdermins offers novel strategies for treating inflammatory diseases and cancer.
  • Further research into gasdermin-targeted therapies is warranted for human health benefits.